on April 6, 2006
Published online before print April 6, 2006, doi: 10.1161/01.ATV.0000220374.00602.a2
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on November 28, 2005
Accepted on March 22, 2006
Biologically Active CD40 Ligand Is Elevated in Sickle Cell Anemia. Potential Role for Platelet-Mediated Inflammation
Sheritha P. Lee ;
From the Departments of Pharmacology (S.P.L., L.V.P.) and Medicine (K.I.A., E.P.O.), the University of North Carolina at Chapel Hill; and Millennium Pharmaceuticals (D.R.P.), South San Francisco, Calif. D.R.P.’s current address: Portola Pharmaceuticals, Inc, South San Francisco, CA 94080.
* To whom correspondence should be addressed. E-mail: parise{at}med.unc.edu.
Objective--After activation, platelets expose CD40 ligand (CD40L) on their surface, then subsequently release the inflammatory mediator as a soluble fragment (sCD40L). Because sickle cell anemia (SCA) is noted for both platelet activation and chronic inflammation, we asked whether platelet-released CD40L potentially plays a role in SCA.
Methods and Results--ELISAs demonstrate that SCA patient plasma contains 30-fold more sCD40L than control plasma. Correspondingly, platelets from these patients contain less than half the CD40L found in control platelets. Platelets from patients in painful crises are further depleted of CD40L, with even higher plasma levels, suggesting a correlation to the patient’s clinical state. In addition, elevated sCD40L correlates with increased tissue factor in SCA plasma. Blockage of the CD40L receptor CD40 reduces SCA plasma-induced production of tissue factor and endothelial intercellular adhesion molecule-1 (ICAM-1). Finally, sCD40L activity in SCA plasma is confirmed by its induction of B-cell proliferation.
Conclusions--Platelet-derived sCD40L is elevated in SCA, further elevated in crises, and biologically active. The participation of sCD40L in SCA plasma-induced production of B cells, tissue factor, and ICAM-1 suggests that CD40L may contribute to the chronic inflammation and increased thrombotic activity known to occur in SCA.
Key words: CD40L • sickle cell anemia • platelets • inflammation • coagulation
Related Article:
- Vasoocclusion in Sickle Cell Anemia: Are Platelets Really Involved?
- Joel S. Bennett
Arterioscler Thromb Vasc Biol 2006 26: 1415-1416.[Extract] [Full Text] [PDF]
This article has been cited by other articles:
 |
|
 |
|
  N. Li Platelet-lymphocyte cross-talk J. Leukoc. Biol., May 1, 2008; 83(5): 1069 - 1078. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Gladwin and G. J. Kato Hemolysis-associated hypercoagulability in sickle cell disease: the plot (and blood) thickens! Haematologica, January 1, 2008; 93(1): 1 - 3. [Full Text] [PDF]
|
|
|
|
|
|
K. I. Ataga, C. G. Moore, C. A. Hillery, S. Jones, H. C. Whinna, D. Strayhorn, C. Sohier, A. Hinderliter, L. V. Parise, and E. P. Orringer Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension Haematologica, January 1, 2008; 93(1): 20 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. von Hundelshausen and C. Weber Platelets as Immune Cells: Bridging Inflammation and Cardiovascular Disease Circ. Res., January 5, 2007; 100(1): 27 - 40. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Telen Role of Adhesion Molecules and Vascular Endothelium in the Pathogenesis of Sickle Cell Disease Hematology, January 1, 2007; 2007(1): 84 - 90. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Bennett Vasoocclusion in sickle cell anemia: are platelets really involved? Arterioscler Thromb Vasc Biol, July 1, 2006; 26(7): 1415 - 1416. [Full Text] [PDF]
|
|